GPR30 activation reverses adverse effects of OVX on exercise capacity in rats.
GPR30 activation prevents OVX-related reductions in peak twitch in soleus muscle.
GPR30 activation inhibits OVX-induced decrease in HSP expression in soleus muscle.
GPR30 activation increases HSP expression in cultured L6 skeletal muscle cells.